Novo is being anti-competitive: Whos right isnt the point
For Canadian researchers following the metabolic peptide field, cagrilintide and the amylin analog category warrant attention as the field continues to expand beyond single, dual, and triple agonist compounds
But coverage is more nuanced than a yes-no decision. Insurers may respond to lower GLP-1 prices by increasing restrictions, which are already stringent, as Klebanoff showed in two studies with LDI Senior Fellows Jalpa Doshi and Judith Long, and colleagues
Adequate protein intake (around 1.6 g per kg of body weight if you're training), two or three resistance sessions a week, consistent sleep, and addressing any underlying issues (thyroid, testosterone, iron) before reaching for a peptide
Hassan A, Tsuda Y, Asai A, et al
We believe in providing an honest, 360-degree view